554 related articles for article (PubMed ID: 33137121)
1. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
[TBL] [Abstract][Full Text] [Related]
2. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M
Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417
[TBL] [Abstract][Full Text] [Related]
4. CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis.
Sfriso P; Cozzi F; Oliviero F; Caso F; Cardarelli S; Facco M; Fittà C; Del Rosso A; Matucci-Cerinic M; Punzi L; Agostini C
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S71-5. PubMed ID: 22691213
[TBL] [Abstract][Full Text] [Related]
5. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease.
Richards TJ; Eggebeen A; Gibson K; Yousem S; Fuhrman C; Gochuico BR; Fertig N; Oddis CV; Kaminski N; Rosas IO; Ascherman DP
Arthritis Rheum; 2009 Jul; 60(7):2183-92. PubMed ID: 19565490
[TBL] [Abstract][Full Text] [Related]
6. The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression.
Yin X; Wang Z; Wu T; Ma M; Zhang Z; Chu Z; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
J Transl Med; 2019 Dec; 17(1):417. PubMed ID: 31836011
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the lavage and serum cytokine profiles of interstitial pneumonia with autoimmune features and their implications for progressive fibrosis.
Zhang Z; Ma X; Bai J; Xia S; Han Q; Luo Q
Rheumatology (Oxford); 2024 May; 63(5):1230-1239. PubMed ID: 37606981
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
9. Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis.
Arger NK; Ho M; Woodruff PG; Koth LL
Respir Med; 2019 Jun; 152():89-96. PubMed ID: 31128616
[TBL] [Abstract][Full Text] [Related]
10. CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages.
Nishioka Y; Manabe K; Kishi J; Wang W; Inayama M; Azuma M; Sone S
Clin Exp Immunol; 2007 Aug; 149(2):317-26. PubMed ID: 17550373
[TBL] [Abstract][Full Text] [Related]
11. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
[TBL] [Abstract][Full Text] [Related]
12. The Role of CXC Chemokines in Pulmonary Fibrosis of Systemic Lupus Erythematosus Patients.
Nielepkowicz-Goździńska A; Fendler W; Robak E; Kulczycka-Siennicka L; Górski P; Pietras T; Brzeziańska E; Pietrusińska M; Antczak A
Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):465-73. PubMed ID: 26275808
[TBL] [Abstract][Full Text] [Related]
13. Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis.
Lim JU; Gil BM; Kang HS; Oh J; Kim YH; Kwon SS
BMC Pulm Med; 2019 Jul; 19(1):120. PubMed ID: 31272428
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
[TBL] [Abstract][Full Text] [Related]
15. Angiostatic versus angiogenic chemokines in IPF and EAA.
Martina S; Martina V; Monika M; Jan P; Libor K; Ilja S
Respir Med; 2009 Nov; 103(11):1651-6. PubMed ID: 19535235
[TBL] [Abstract][Full Text] [Related]
16. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
[TBL] [Abstract][Full Text] [Related]
17. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
[TBL] [Abstract][Full Text] [Related]
18. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases.
Nakashima T; Omori K; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
Respir Med; 2023 Jun; 212():107224. PubMed ID: 37003499
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria.
Bozzao F; Tomietto P; Baratella E; Kodric M; Cifaldi R; Della Porta R; Prearo I; Pirronello SMG; Confalonieri P; Ruaro B; Fischetti F; Fabris B
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109752
[No Abstract] [Full Text] [Related]
20. [Interstitial pneumonia with autoimmune features: monocentric prospective study].
Akulkina LA; Shchepalina AA; Moiseev AS; Brovko MY; Sholomova VI; Moiseev SV
Ter Arkh; 2023 Apr; 95(3):224-229. PubMed ID: 37167143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]